Kevin Yeaman - Aug 16, 2022 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
Stock symbol
DLB
Transactions as of
Aug 16, 2022
Transactions value $
-$617,790
Form type
4
Date filed
8/17/2022, 09:44 PM
Previous filing
Feb 11, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $717 K +16.7 K +76.76% $42.98 38.4 K Aug 16, 2022 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
transaction DLB Class A Common Stock Sale -$1.34 M -16.7 K -43.43% $80.00 21.7 K Aug 16, 2022 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
holding DLB Class A Common Stock 108 K Aug 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -16.7 K -8.85% $0.00 172 K Aug 16, 2022 Class A Common Stock 16.7 K $42.98 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F2

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 107,579 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2 This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.

Remarks:

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.